HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcello Galvani Selected Research

Stroke (Strokes)

1/2021[Periprocedural management of anticoagulation therapy and in-hospital outcomes in patients with warfarin indication undergoing percutaneous coronary intervention. Data from the WAR-STENT registry].
5/2015Sex-Related Outcomes in Elderly Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome: Insights From the Italian Elderly ACS Study.
4/2013In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
3/2008Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study.
1/2007Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcello Galvani Research Topics

Disease

17Acute Coronary Syndrome
12/2020 - 01/2002
14Myocardial Infarction
01/2021 - 05/2002
11Hemorrhage
09/2021 - 10/2003
8ST Elevation Myocardial Infarction
09/2018 - 03/2004
6Thrombosis (Thrombus)
01/2021 - 05/2002
6Infarction (Infarctions)
08/2018 - 09/2002
5Necrosis
04/2024 - 09/2002
5Atrial Fibrillation
03/2024 - 07/2005
5Stroke (Strokes)
01/2021 - 01/2007
5Heart Failure
10/2017 - 01/2002
5Myocardial Ischemia (Ischemic Heart Diseases)
07/2004 - 01/2002
4Ischemia
03/2008 - 09/2002
3Thromboembolism
11/2014 - 01/2007
3Cardiovascular Diseases (Cardiovascular Disease)
02/2009 - 01/2002
2Venous Thromboembolism
01/2021 - 04/2013
2Unstable Angina
01/2019 - 10/2003
2Atrial Flutter (Flutter, Atrial)
02/2011 - 07/2005
2Inflammation (Inflammations)
09/2010 - 09/2004
1Delirium
04/2024
1Heart Diseases (Heart Disease)
02/2024
1Heart Arrest (Cardiac Arrest)
10/2022
1Coma (Comas)
10/2022
1Pulmonary Embolism
09/2021
1Aortic Valve Insufficiency (Aortic Regurgitation)
01/2021
1Aortitis
01/2021
1COVID-19
12/2020
1Frailty
10/2019
1Aneurysm (Aneurysms)
09/2018
1Chest Pain (Chest Pains)
01/2012
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2009
1Tachycardia (Tachyarrhythmias)
11/2008
1Cardiomyopathies (Cardiomyopathy)
11/2008
1Atrioventricular Block
11/2008
1Cardiac Arrhythmias (Arrythmia)
11/2008
1Coronary Disease (Coronary Heart Disease)
05/2007
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2007
1Renal Insufficiency (Renal Failure)
01/2007
1Left Ventricular Dysfunction
03/2004
1Neutropenia
10/2003
1Thrombocytopenia (Thrombopenia)
10/2003
1Hemorrhagic Stroke
05/2002
1Rupture
05/2002

Drug/Important Bio-Agent (IBA)

8TroponinIBA
09/2013 - 09/2002
6Biomarkers (Surrogate Marker)IBA
01/2012 - 09/2002
5omega-Chloroacetophenone (Mace)IBA
01/2019 - 02/2009
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2019 - 11/2014
3Clopidogrel (Plavix)FDA Link
03/2018 - 10/2003
2Heparin (Liquaemin)FDA LinkGeneric
09/2021 - 01/2007
2Prasugrel HydrochlorideFDA Link
01/2020 - 03/2018
2Troponin IIBA
10/2011 - 09/2004
2FibrinIBA
01/2007 - 05/2002
2Glycoproteins (Glycoprotein)IBA
01/2007 - 05/2002
2Natriuretic PeptidesIBA
07/2004 - 03/2004
2pro-brain natriuretic peptide (1-76)IBA
07/2004 - 03/2004
2ThrombinFDA Link
10/2003 - 05/2002
1fibrin fragment D (D-dimer)IBA
04/2024
1CabergolineFDA LinkGeneric
02/2024
1AnticoagulantsIBA
09/2021
1DabigatranFDA Link
09/2021
1TicagrelorIBA
01/2020
1Troponin T (Troponin T1)IBA
01/2019
1Nicorandil (SG 75)IBA
10/2017
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2017
1Metoprolol (Toprol-XL)FDA LinkGeneric
10/2017
1Fibrinogen (Factor I)FDA Link
09/2012
1DronedaroneFDA Link
05/2012
1Eptifibatide (Integrilin)FDA Link
07/2010
1Abciximab (ReoPro)FDA Link
07/2010
1Tirofiban (Aggrastat)FDA Link
07/2010
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2009
1Adenosine (Adenocard)FDA LinkGeneric
11/2008
1CreatinineIBA
03/2008
1reviparin (reviparin-sodium)IBA
01/2007
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2007
1Dalteparin (Dalteparin Sodium)FDA Link
01/2007
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2007
1Anti-Arrhythmia AgentsIBA
07/2005
1C-Reactive ProteinIBA
09/2004
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2004
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2003
1AntithrombinsIBA
09/2003
1Plasminogen Activators (Plasminogen Activator)IBA
05/2002
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2002
1Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2002
1Platelet Membrane Glycoprotein IIbIBA
05/2002
1reteplaseFDA Link
05/2002

Therapy/Procedure

11Therapeutics
03/2024 - 05/2002
9Percutaneous Coronary Intervention
09/2018 - 09/2002
4Patient Readmission
10/2017 - 03/2008
3Stents
01/2021 - 02/2009
3Catheter Ablation
04/2014 - 07/2005
2Thrombolytic Therapy
09/2018 - 05/2002
1Induced Hypothermia
10/2022
1Transcatheter Aortic Valve Replacement
01/2021
1Artificial Respiration (Mechanical Ventilation)
12/2020
1Catheters
04/2014
1Blood Transfusion (Blood Transfusions)
02/2009
1Myocardial Revascularization
02/2009
1Conservative Treatment
03/2008
1Length of Stay
03/2004